Growing the love for investing
Results 11 - 20 of 29 : Previous 1 2 3 Next
It can pay to catch rising stars.
It can pay to catch rising stars.
Some investors are warming up to these previously unloved companies.
Some investors are getting behind these stocks that may be set to run.
The FDA Leaves Pfizer in the Waiting Room
The EU loves its new osteoporosis drug, but what about the U.S.?
Glaxo Cuts Jobs, Guidance -- and the Kitchen Sink
With sales dropping, more cuts were inevitable.
While low-priced stocks can be cheap for a reason, they might also present some great, overlooked investment opportunities.
Is Amgen's Nplate a Blockbuster?
Amgen gets a positive recommendation from European officials.
Ligand and Glaxo Like the FDA's Answer
Good news arrives for blood-clot buster Promacta.
See what the best CAPS players recommend now.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK